EPH236 The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
Abstract
Authors
Burcu Akyol Ersoy Yasemin Ceylan Ugur Akpamuk Gozde Ozcan Yasemin Esen Mert Batum Mert Oklay Bernadette Poellinger Carole Mamane Amin Haiderali Aurelien Jamotte Simten Malhan Irfan Cicin